Literature DB >> 5044818

Mass spectrometric characterization of carbamazepine-10,11-epoxide, a carbamazepine metabolite isolated from human urine.

A Frigerio, R Fanelli, P Biandrate, G Passerini, P L Morselli, S Garattini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5044818     DOI： 10.1002/jps.2600610724

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  10 in total

1.  A new N-glucuronide metabolite of carbamazepine.

Authors:  J E Bauer; N Gerber; R K Lynn; R G Smith; R M Thompson
Journal:  Experientia       Date:  1976-08-15

2.  Inhibition of liver microsomal epoxide hydrase by cyproheptadine epoxide.

Authors:  J Pachecka; M Salmona; G Belvedere; L Cantoni; E Mussini; S Garattini
Journal:  Experientia       Date:  1977-04-15

3.  Plasma kinetics of carbamazepine and its epoxide metabolite in man after single and multiple doses.

Authors:  M Eichelbaum; K Ekbom; L Bertilsson; V A Ringberger; A Rane
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

4.  Formation of cis-14,15-oxido-5,8,11-icosatrienoic acid from phosphatidylinositol in human platelets.

Authors:  L R Ballou; B K Lam; P Y Wong; W Y Cheung
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

5.  Clinical pharmacokinetics in infants and children.

Authors:  A Rane; J T Wilson
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

6.  Graded doses of grape seed methanol extract attenuated hepato-toxicity following chronic carbamazepine treatment in male Wistar rats.

Authors:  Opeyemi Samson Osuntokun; Gbola Olayiwola; Tope Gafar Atere; Kabiru Isola Adedokun; Olayemi Olutobi Oladokun
Journal:  Toxicol Rep       Date:  2020-11-24

7.  Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.

Authors:  M Eichelbaum; L Bertilsson; L Lund; L Palmér; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

8.  Recent advances in drug therapy for epilepsy.

Authors:  J Bruni
Journal:  Can Med Assoc J       Date:  1979-04-07       Impact factor: 8.262

Review 9.  Pharmacologically active drug metabolites: therapeutic and toxic activities, plasma and urine data in man, accumulation in renal failure.

Authors:  D E Drayer
Journal:  Clin Pharmacokinet       Date:  1976 Nov-Dec       Impact factor: 6.447

Review 10.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.